Price K M, Van Lith J M, Silman R, Mantingh A, Grudzinskas J G
Department of Obstetrics and Gynaecology, St Bartholomew's & the Royal London School of Medicine and Dentistry, Queen Mary & Westfield College, UK.
Hum Reprod. 1998 Jun;13(6):1706-8. doi: 10.1093/humrep/13.6.1706.
Serum concentrations of fetal antigen 2 (FA-2), the amino-propeptide of the alpha1 chain of collagen type I, were measured in peripheral blood from women with normal (n = 234) and trisomy 21 affected (n = 14) pregnancies between 9 and 11 weeks gestation. Serum FA-2 concentrations were seen to be stable throughout this period, and though raised FA-2 concentrations were seen at the 10th week of gestation, a statistically significant difference between normal and trisomy 21 affected pregnancies was not found overall. Therefore it seems unlikely that FA-2 has a role in first trimester screening for trisomy 21, despite the fact that significantly higher FA-2 concentrations in trisomy 21 and significantly lower concentrations in trisomy 18 had been previously demonstrated in amniotic fluid in the second trimester.
在妊娠9至11周的正常妊娠(n = 234)和21三体综合征妊娠(n = 14)女性的外周血中,检测了胎儿抗原2(FA-2,即I型胶原α1链的氨基前肽)的血清浓度。在此期间,血清FA-2浓度保持稳定,尽管在妊娠第10周时观察到FA-2浓度升高,但总体上未发现正常妊娠与21三体综合征妊娠之间存在统计学显著差异。因此,尽管先前已证实在妊娠中期羊水中,21三体综合征患者的FA-2浓度显著升高,而18三体综合征患者的浓度显著降低,但FA-2似乎不太可能用于孕早期21三体综合征的筛查。